Thomas, Philip

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
25 96% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Thomas, Philip's trades of GSK plc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-14 2026-07-09
GB GSK plc (GSK)
B Purchase
43,905
328.16
£1,757,268 		43,905 328.16 £1,757,268
2026-07-13 2026-07-09
GB GSK plc (GSK)
B Purchase
95,824
325.01
£2,285,115 		95,824 325.01 £2,285,115
2026-07-13 2026-07-09
GB GSK plc (GSK)
B Purchase
11,284
150.87
£1,962,009 		11,284 150.87 £1,962,009
2026-06-11 2026-06-09
GB GSK plc (GSK)
B Purchase
14
18.84
£264 		14 18.84 £264
2026-05-14 2026-05-12
GB GSK plc (GSK)
B Purchase
12
18.66
£224 		12 18.66 £224
2026-04-14 2026-04-13
GB GSK plc (GSK)
B Purchase
12
21.71
£260 		12 21.71 £260
2026-04-13 2026-04-09
GB GSK plc (GSK)
B Purchase
2,306
21.50
£49,578 		2,306 21.50 £49,578
2026-04-10 2026-04-09
GB GSK plc (GSK)
B Purchase
44
21.34
£939 		44 21.34 £939
2026-03-12 2026-03-10
GB GSK plc (GSK)
B Purchase
12
20.72
£249 		12 20.72 £249
2026-02-11 2026-02-10
GB GSK plc (GSK)
B Purchase
12
21.79
£262 		12 21.79 £262
2026-01-13 2026-01-12
GB GSK plc (GSK)
B Purchase
12
18.93
£227 		12 18.93 £227
2026-01-13 2026-01-08
GB GSK plc (GSK)
B Purchase
1,875
18.95
£35,520 		1,875 18.95 £35,520
2026-01-13 2026-01-08
GB GSK plc (GSK)
B Purchase
43
18.94
£815 		43 18.94 £815
2025-12-11 2025-12-09
GB GSK plc (GSK)
PP Planned purchase
14
18.08
£253 		14 18.08 £253
2025-09-10 2025-09-09
GB GSK plc (GSK)
PP Planned purchase
16
14.86
£238 		16 14.86 £238
2025-08-12 2025-08-11
GB GSK plc (GSK)
PP Planned purchase
18
14.08
£254 		18 14.08 £254
2024-12-12 2024-12-10
GB GSK plc (GSK)
B Purchase
18
13.92
£251 		18 13.92 £251
2024-11-12 2024-11-11
GB GSK plc (GSK)
B Purchase
18
13.99
£252 		18 13.99 £252
2024-10-17 2024-10-15
GB GSK plc (GSK)
B Purchase
1,692
14.87
£25,165 		1,692 14.87 £25,165
2024-10-11 2024-10-10
GB GSK plc (GSK)
B Purchase
45
15.26
£687 		45 15.26 £687
2024-10-10 2024-10-09
GB GSK plc (GSK)
B Purchase
18
14.52
£261 		18 14.52 £261
2024-09-12 2024-09-10
GB GSK plc (GSK)
B Purchase
14
16.69
£234 		14 16.69 £234
2024-08-12 2024-08-09
GB GSK plc (GSK)
B Purchase
16
15.51
£248 		16 15.51 £248
2024-07-15 2024-07-11
GB GSK plc (GSK)
B Purchase
45
15.13
£681 		45 15.13 £681
2024-07-12 2024-07-09
GB GSK plc (GSK)
B Purchase
18
15.19
£273 		18 15.19 £273
2024-06-12 2024-06-11
GB GSK plc (GSK)
B Purchase
14
16.23
£227 		14 16.23 £227
2024-05-14 2024-05-10
GB GSK plc (GSK)
B Purchase
14
17.94
£251 		14 17.94 £251
2024-04-15 2024-04-11
GB GSK plc (GSK)
B Purchase
43
16.31
£701 		43 16.31 £701
2024-04-15 2024-04-10
GB GSK plc (GSK)
B Purchase
16
16.13
£258 		16 16.13 £258
2024-03-13 2024-03-11
GB GSK plc (GSK)
B Purchase
16
16.66
£267 		16 16.66 £267
2022-12-15 2022-12-14
S Sale
7,704 -80.6%
67.65
CA$521,176 		7,704 -80.6% 67.65 CA$521,176